In combination w/ prednisone or prednisolone for the treatment of metastatic prostate cancer in asymptomatic or mildly symptomatic patients after failure of androgen deprivation therapy (ADT) or have received prior chemotherapy containing taxane; w/ androgen deprivation therapy & prednisone or prednisolone is indicated for the treatment of adult men w/ newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC).